Literature DB >> 6292033

The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.

S Sandler, A Andersson.   

Abstract

The protective effect on streptozotocin-induced diabetes of dimethyl urea, a hydroxyl radical scavenger, has been evaluated in vivo and in vitro. Pretreatment with dimethyl urea before a single diabetogenic dose of streptozotocin partially protected NMRI mice from hyperglycaemia, whereas the serum glucose of C57BL/KsJ mice increased during week 2 of observation. When the pancreases of these latter mice were examined histologically, insulitis was found in 15 out of 22 animals. The protective effect of dimethyl urea in the NMRI mice was not due to short-term hyperglycaemia induced by the drug, since pretreatment with glucose did not protect from streptozotocin but potentiated its diabetogenic effect. Dimethyl urea reduced the inhibition caused by streptozotocin on proinsulin biosynthesis of NMRI islets in vitro. It is suggested that streptozotocin-induced diabetes in mice may involve generation of hydroxyl radicals which are toxic to islet B cells. If this immediate cytoxicity is reduced by a scavenger, a more slowly developing hyperglycaemia and an accompanying insulitis may occur in particularly susceptible animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292033     DOI: 10.1007/bf00253747

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea.

Authors:  C J Skidmore; M I Davies; P M Goodwin; H Halldorsson; P J Lewis; S Shall; A A Zia'ee
Journal:  Eur J Biochem       Date:  1979-11-01

2.  Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate.

Authors:  R E Heikkila; B Winston; G Cohen
Journal:  Biochem Pharmacol       Date:  1976-05-01       Impact factor: 5.858

3.  Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.

Authors:  W E Dulin; B M Wyse
Journal:  Diabetes       Date:  1969-07       Impact factor: 9.461

4.  Anti-insulin serum coupled to Sepharose 4B as a tool for the investigation of insulin biosynthesis in the B-cells of obese hyperglycemic mice.

Authors:  C Berne
Journal:  Endocrinology       Date:  1975-11       Impact factor: 4.736

5.  Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets.

Authors:  H Yamamoto; H Okamoto
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

6.  Protection against streptozotocin-induced diabetes by superoxide dismutase.

Authors:  M J Robbins; R A Sharp; A E Slonim; I M Burr
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

7.  Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator.

Authors:  L J Fischer; S A Hamburger
Journal:  Diabetes       Date:  1980-03       Impact factor: 9.461

8.  Protection against alloxan-induced diabetes in mice by the hydroxyl radical scavenger dimethylurea.

Authors:  R E Heikkila; E S Cabbat
Journal:  Eur J Pharmacol       Date:  1978-11-01       Impact factor: 4.432

9.  Studies on streptozotocin diabetes.

Authors:  O P Ganda; A A Rossini; A A Like
Journal:  Diabetes       Date:  1976-07       Impact factor: 9.461

10.  Islet implantation into diabetic mice with pancreatic insulitis.

Authors:  S Sandler; A Andersson
Journal:  Acta Pathol Microbiol Scand A       Date:  1981-03
View more
  16 in total

1.  Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status.

Authors:  Manisha A Modak; Savita P Datar; Ramesh R Bhonde; Saroj S Ghaskadbi
Journal:  J Comp Physiol B       Date:  2007-01-05       Impact factor: 2.200

2.  Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin.

Authors:  D L Eizirik; E Strandell; S Sandler
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

3.  Protection of islet cells from inflammatory cell death in vitro.

Authors:  V Burkart; H Kolb
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

4.  Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes.

Authors:  A E Slonim; M L Surber; D L Page; R A Sharp; I M Burr
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro.

Authors:  D Boillot; P in't Veld; P Sai; G Feutren; W Gepts; R Assan
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

6.  Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.

Authors:  R C McEvoy; J Andersson; S Sandler; C Hellerström
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

Review 7.  The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae).

Authors:  I E Cock
Journal:  Inflammopharmacology       Date:  2015-07-31       Impact factor: 4.473

8.  Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse.

Authors:  S Sandler
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

9.  Vascular permeability of pancreatic islets after administration of streptozotocin.

Authors:  S Sandler; L Jansson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells.

Authors:  G L Wilson; N J Patton; J M McCord; D W Mullins; B T Mossman
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.